Schott Pharma Ag & CO Kgaa (1SXP.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | |
| Sales | 223,517 | 225,216 | 203,036 |
| Cost of Goods | 136,613 | 144,004 | 140,313 |
| Gross Profit | 86,904 | 81,212 | 62,723 |
| Operating Expenses | 40,086 | 33,449 | 12,991 |
| Operating Income | 46,818 | 47,763 | 49,732 |
| Interest Expense | 1,561 | 1,294 | 1,088 |
| Other Income | 15,441 | 2,614 | -16,384 |
| Pre-tax Income | 60,698 | 49,083 | 32,260 |
| Income Tax | 12,185 | 10,926 | 6,618 |
| Net Income Continuous | 48,513 | 38,157 | 25,642 |
| Minority Interests | 2 | -16 | -59 |
| Net Income | $48,515 | $38,141 | $25,584 |
| EPS Basic Total Ops | 0.32 | 0.25 | 0.17 |
| EPS Diluted Total Ops | 0.32 | 0.25 | 0.17 |
| EBITDA(a) | $69,104 | $62,922 | $46,231 |